Alopecia Areata: The Clinical Situation

    Maria Hordinsky
    Image of study
    TLDR Treating alopecia areata is difficult due to limited approved treatments, but new therapies like JAK inhibitors show promise.
    In 2018, treating alopecia areata (AA) was challenging due to the lack of FDA-approved treatments, requiring physicians to consider various off-label options based on patient age, hair loss location, disease extent, and other medical or psychological factors. The growing interest in JAK inhibitors highlighted the need for discussions about both traditional off-label treatments and emerging therapies during clinical visits.
    Discuss this study in the Community →

    Research cited in this study

    10 / 10 results

    Related Community Posts Join

    6 / 1000+ results

    Related Research

    5 / 5 results